| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |